Stock Price Forecast

April 22, 2024


Forecasted Returns

7 Days Predict

30 Days Predict

90 Days Predict


Forecasted Market-Excess Returns

7 Days Predict

30 Days Predict

90 Days Predict

Loading VOLITIONRX LTD chart...

About the Company

We do not have any company description for VOLITIONRX LTD at the moment.

Exchange

NYSE

$0M

Total Revenue

58

Employees

$49M

Market Capitalization

2.50

Price/Earning ratio

Fundamental Data and Insider Transactions (Quarterly data) Full Screen

Loading the fundamentals chart...

Latest $VNRX News

VolitionRX Ltd (VNRX) Shares Plummet Below 1-Year High

3d ago, source: newsheater

Reports are indicating that there were more than several insider trading activities at VNRX starting from Eight Corp Ltd, who sale 20,000 shares at the price of $0.90 back on Jan 02 ’24. After this ...

VolitionRX Ltd VNRX

12d ago, source: Morningstar

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...

VNRX: VolitionRx Reports 2023 Results; Distribution of Nu.Q Vet Test Expanding; Nu.Q Discover Growing; Two Key R&D Efforts in 2024/25: 1) Breakthrough Cancer D…

14d ago, source: Zacks Small Cap Research on MSN

The Nu.Q Vet Cancer Test is currently available in • the U.S. (initial product launch in November 2020 through direct sales ...

Volitionrx Limited

4mon ago, source: CNN

VolitionRX Ltd. engages in the development of blood-based cancer tests to help diagnose a range of cancers. Its products include the Nucleosomics platform that identifies and measures nucleosomes ...

Volitionrx Ltd earnings beat, revenue fell short of estimates

28d ago, source: Investing

Investing.com - Volitionrx Ltd (NYSE: VNRX) reported first quarter EPS of $-0.100, better than the analyst estimate of $-0.108. Revenue for the quarter came in at $235K versus the consensus ...

VolitionRx Limited Announces Full Fiscal Year 2023 Financial Results and Business Update

28d ago, source: Stockhouse

March 25, 2024 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, today announced financial results and a business update for the full fiscal ...

Volitionrx Ltd (VNRX) Earnings Dates & Reports

29d ago, source: Investing

View upcoming earnings forecasts and in-depth analysis of company forecasts.

Volition and Fujifilm Vet Systems Launch Nu.Q® Vet Cancer Test in Japan

1mon ago, source: Stockhouse

HENDERSON, Nev. , March 20, 2024 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, has agreed a supply agreement with Fujifilm Vet Systems Co ...

Transocean Ltd. (RIG)

21h ago, source: Yahoo Finance

STEINHAUSEN, Switzerland, April 18, 2024 (GLOBE NEWSWIRE) -- Transocean Ltd. (NYSE: RIG) announced today on behalf of Transocean Inc., its wholly-owned subsidiary (the “Company” and ...

VolitionRX Ltd

5d ago, source: U.S. News & World Report

Invest with your heart and your phone with as little as $1 with these ESG and socially responsible investing apps.

Volitionrx Ltd earnings beat, revenue fell short of estimates

28d ago, source: Investing

Investing.com - Volitionrx Ltd (NYSE: VNRX) reported first quarter EPS of $-0.100, better than the analyst estimate of $-0.108. Revenue for the quarter came in at $235K versus the consensus estimate ...

Volition and Fujifilm Vet Systems Launch Nu.Q® Vet Cancer Test in Japan

1mon ago, source: Yahoo Finance

March 20, 2024 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, has agreed a supply agreement with Fujifilm Vet Systems Co. Ltd ...

Latest Neutral (free) Forecasts

STRONG BUY BUY NEUTRAL SELL STRONG SELL ALL

Loading the latest forecasts...

My Portfolio

Loading your portfolio...